Table 3.6 shows the 50 most frequent, separately billed drugs and biologicals associated with services in the HOPS and ED.28 In both the HOPS and ED, imaging contrast material, blood products and medications associated with cancer chemotherapy are among the most frequently used. In the ED, several thrombolytic agents are also frequently used. These findings derive from the data provided by CMS and have not been aggregated by drug or drug class. Additional analyses of drugs and biologicals would inform opportunities for measure development.
HOPS
|
Emergency Department
|
||||
---|---|---|---|---|---|
APC | APC definition | Volume | APC | APC definition | Volume |
4646 | Contrast 300-399 MGs iodine | 951,639 | 768 | Ondansetron hcl injection | 180,380 |
733 | Non esrd epoetin alpha inj | 610,121 | 4646 | Contrast 300-399 MGs iodine | 124,136 |
768 | Ondansetron hcl injection | 486,806 | 750 | Dolasetron mesylate | 27,611 |
1600 | Tc99m sestamibi | 359,301 | 1600 | Tc99m sestamibi | 26,186 |
954 | RBC leukocytes reduced | 309,368 | 954 | RBC leukocytes reduced | 21,140 |
734 | Darbepoetin alfa, non esrd | 303,060 | 705 | Tc99m tetrofosmin | 17,722 |
9027 | Supp- paramagnetic contr mat | 209,894 | 9223 | Inj adenosine, tx dx | 17,236 |
705 | Tc99m tetrofosmin | 203,824 | 7028 | Fosphenytoin, 50 mg | 10,410 |
1775 | FDG, per dose (4-40 mCi/ml) | 146,799 | 1603 | TL201 thallium | 10,313 |
750 | Dolasetron mesylate | 137,086 | 4644 | Contrast 100-199 MGs iodine | 9,483 |
4645 | Contrast 200-299 MGs iodine | 130,186 | 733 | Non esrd epoetin alpha inj | 9,161 |
764 | Granisetron HCl injection | 125,375 | 764 | Granisetron HCl injection | 8,755 |
1603 | TL201 thallium | 121,426 | 9042 | Glucagon hydrochloride/1 MG | 8,395 |
9223 | Inj adenosine, tx dx | 119,916 | 4645 | Contrast 200-299 MGs iodine | 7,956 |
9115 | Zoledronic acid | 104,174 | 9027 | Supp- paramagnetic contr mat | 7,716 |
9114 | Nesiritide | 89,536 | 959 | Red blood cells unit | 6,989 |
811 | Carboplatin injection | 87,670 | 1670 | Tetanus immune globulin inj | 6,938 |
4644 | Contrast 100-199 MGs iodine | 83,853 | 9508 | Plasma 1 donor frz w/in 8 hr | 5,790 |
863 | Paclitaxel injection | 82,377 | 3033 | Technetium tc-99m pentetate | 5,539 |
959 | Red blood cells unit | 81,503 | 1607 | Eptifibatide injection | 3,564 |
828 | Gemcitabine HCl | 72,729 | 379 | Injection adenosine 6 MG | 3,289 |
728 | Filgrastim 300 mcg injection | 67,612 | 935 | Clonidine hydrochloride | 3,265 |
9119 | Injection, pegfilgrastim 6mg | 67,361 | 9139 | Rabies vaccine, im | 3,173 |
7043 | Infliximab injection | 65,192 | 917 | Adenosine injection | 3,086 |
765 | Granisetron HCl 1 mg oral | 64,247 | 734 | Darbepoetin alfa, non esrd | 2,081 |
HOPS |
Emergency Department |
||||
---|---|---|---|---|---|
APC |
APC definition |
Volume |
APC |
APC definition |
Volume |
4646 | Contrast 300-399 MGs iodine |
951,639 |
0768 | Ondansetron hcl injection |
180,380 |
0733 | Non esrd epoetin alpha inj |
610,121 |
4646 | Contrast 300-399 MGs iodine |
124,136 |
0768 | Ondansetron hcl injection |
486,806 |
0750 | Dolasetron mesylate |
27,611 |
1600 | Tc99m sestamibi |
359,301 |
1600 | Tc99m sestamibi |
26,186 |
0954 | RBC leukocytes reduced |
309,368 |
0954 | RBC leukocytes reduced |
21,140 |
0734 | Darbepoetin alfa, non esrd |
303,060 |
0705 | Tc99m tetrofosmin |
17,722 |
9027 | Supp- paramagnetic contr mat |
209,894 |
9223 | Inj adenosine, tx dx |
17,236 |
0705 | Tc99m tetrofosmin |
203,824 |
7028 | Fosphenytoin, 50 mg |
10,410 |
1775 | FDG, per dose (4-40 mCi/ml) |
146,799 |
1603 | TL201 thallium |
10,313 |
0750 | Dolasetron mesylate |
137,086 |
4644 | Contrast 100-199 MGs iodine |
9,483 |
4645 | Contrast 200-299 MGs iodine |
130,186 |
0733 | Non esrd epoetin alpha inj |
9,161 |
0764 | Granisetron HCl injection |
125,375 |
0764 | Granisetron HCl injection |
8,755 |
1603 | TL201 thallium |
121,426 |
9042 | Glucagon hydrochloride/1 MG |
8,395 |
9223 | Inj adenosine, tx dx |
119,916 |
4645 | Contrast 200-299 MGs iodine |
7,956 |
9115 | Zoledronic acid |
104,174 |
9027 | Supp- paramagnetic contr mat |
7,716 |
9114 | Nesiritide |
89,536 |
0959 | Red blood cells unit |
6,989 |
0811 | Carboplatin injection |
87,670 |
1670 | Tetanus immune globulin inj |
6,938 |
4644 | Contrast 100-199 MGs iodine |
83,853 |
9508 | Plasma 1 donor frz w/in 8 hr |
5,790 |
0863 | Paclitaxel injection |
82,377 |
3033 | Technetium tc-99m pentetate |
5,539 |
0959 | Red blood cells unit |
81,503 |
1607 | Eptifibatide injection |
3,564 |
0828 | Gemcitabine HCl |
72,729 |
0379 | Injection adenosine 6 MG |
3,289 |
0728 | Filgrastim 300 mcg injection |
67,612 |
0935 | Clonidine hydrochloride |
3,265 |
9119 | Injection, pegfilgrastim 6mg |
67,361 |
9139 | Rabies vaccine, im |
3,173 |
7043 | Infliximab injection |
65,192 |
0917 | Adenosine injection |
3,086 |
0765 | Granisetron HCl 1 mg oral |
64,247 |
0734 | Darbepoetin alfa, non esrd |
2,081 |
HOPS |
Emergency Department |
||||
---|---|---|---|---|---|
APC |
APC definition |
Volume |
APC |
APC definition |
Volume |
7049 | Filgrastim 480 mcg injection |
60,354 |
9112 | Inj perflutren lip micros,ml |
1,926 |
0849 | Rituximab cancer treatment |
59,390 |
7048 | Alteplase recombinant |
1,762 |
9210 | Palonosetron HCl |
55,903 |
3030 | Sumatriptan succinate / 6 MG |
1,695 |
0823 |
Docetaxel |
54,261 |
0769 |
Ondansetron HCl 8mg oral |
1,571 |
0869 |
IVIG lyophil 1g |
44,227 |
9501 |
Platelet pheres leukoreduced |
1,557 |
9042 |
Glucagon hydrochloride/1 MG |
42,442 |
9114 |
Nesiritide |
1,459 |
9046 |
Iron sucrose injection |
40,848 |
7049 |
Filgrastim 480 mcg injection |
1,424 |
0769 |
Ondansetron HCl 8mg oral |
38,847 |
0728 |
Filgrastim 300 mcg injection |
1,202 |
9501 |
Platelet pheres leukoreduced |
38,257 |
9015 |
Mycophenolate mofetil oral |
1,172 |
0730 |
Pamidronate disodium /30 MG |
36,150 |
0891 |
Tacrolimus oral per 1 MG |
1,167 |
9148 |
I123 iodide cap, dx |
35,333 |
9002 |
Tenecteplase injection |
1,112 |
7316 |
Sodium hyaluronate injection |
35,074 |
9202 |
Inj octafluoropropane mic,ml |
1,001 |
0969 |
RBC leukoreduced irradiated |
34,997 |
9005 |
Reteplase injection |
965 |
9214 |
Bevacizumab injection |
33,170 |
0965 |
Albumin (human), 25%, 50ml |
891 |
1613 |
Trastuzumab |
32,886 |
9133 |
Rabies ig, im/sc |
883 |
0830 |
Irinotecan injection |
32,192 |
0969 |
RBC leukoreduced irradiated |
877 |
0917 |
Adenosine injection |
31,416 |
9124 |
Daptomycin injection |
683 |
9205 |
Oxaliplatin |
30,843 |
9026 |
High dose contrast MRI |
664 |
9124 |
Daptomycin injection |
29,519 |
9044 |
Ibutilide fumarate injection |
639 |
0871 |
IVIG non-lyophil 1g |
28,313 |
0811 |
Carboplatin injection |
558 |
3048 |
Doxorubic hcl 10 MG vl chemo |
26,629 |
9155 |
Technetium tc99mlabeledrbcs |
528 |
7000 |
Amifostine |
25,682 |
0888 |
Cyclosporine oral 100 mg |
505 |
9218 |
Injection, Azacitidine |
25,349 |
9025 |
Rubidium-Rb-82 |
485 |
1622 |
Technetium tc99m mertiatide |
24,340 |
9046 |
Iron sucrose injection |
474 |
9207 |
Bortezomib injection |
24,216 |
1019 |
Plate pheres leukoredu irrad |
473 |
View full report

"outpatient.pdf" (pdf, 1001.94Kb)
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®